Fennec Pharmaceuticals (FENC) Cash from Operations (2010 - 2025)
Fennec Pharmaceuticals posted quarterly Cash from Operations of 5962000.0 for Q4 2025, down 304.48% year-on-year from 2915722.63 in Q4 2024, and down 499.33% on a QoQ basis from 1493000.0 in Q3 2025.
Fennec Pharmaceuticals (FENC) has 16 years of Cash from Operations data on file, last reported at 5962000.0 in Q4 2025.
- For the quarter ending Q4 2025, Cash from Operations fell 304.48% year-over-year to 5962000.0; the trailing twelve-month figure through Dec 2025 stood at 12473000.0 (down 146.23% YoY), and the FY2025 full-year result was 12473000.0, down 146.23% from the prior year.
- Cash from Operations for Q4 2025 stood at 5962000.0, down from 1493000.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 39047000.0 in Q1 2024 and bottomed at 8387000.0 in Q2 2024.
- The 5-year median for Cash from Operations is 3639500.0 (2021), against an average of 1745800.0.
- The widest annual swing landed in 2024, when Cash from Operations surged 800.14%; it then sank 304.48% in 2025.
- A 5-year view of Cash from Operations shows it stood at 3245000.0 in 2021, then plunged by 109.61% to 6802000.0 in 2022, then gained by 28.55% to 4860000.0 in 2023, then soared by 69.67% to 1474000.0 in 2024, then tumbled by 304.48% to 5962000.0 in 2025.
- The last three Cash from Operations figures came in at 5962000.0 (Q4 2025), 1493000.0 (Q3 2025), and 3686000.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -1.67 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -12.20 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -2.49 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.43 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 1.08 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 70.50 Mn |
| 10 | Fennec Pharmaceuticals | 281.48 Mn | 244.70 Mn | 7.67 Mn | -5.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -5.96 Mn |
| Dec 31, 2025 | -5.96 Mn |
| Sep 30, 2025 | 1.49 Mn |
| Sep 30, 2025 | 1.49 Mn |
| Jun 30, 2025 | -3.69 Mn |
| Jun 30, 2025 | -3.69 Mn |
| Mar 31, 2025 | -4.32 Mn |
| Mar 31, 2025 | -4.32 Mn |
| Dec 31, 2024 | -1.47 Mn |
| Dec 31, 2024 | -1.47 Mn |
| Sep 30, 2024 | -2.21 Mn |
| Sep 30, 2024 | -2.21 Mn |
| Jun 30, 2024 | -8.39 Mn |
| Jun 30, 2024 | -8.39 Mn |
| Mar 31, 2024 | 39.05 Mn |
| Mar 31, 2024 | 39.05 Mn |
| Dec 31, 2023 | -4.86 Mn |
| Dec 31, 2023 | -4.86 Mn |
| Sep 30, 2023 | -2.76 Mn |
| Sep 30, 2023 | -2.76 Mn |
| Jun 30, 2023 | -3.95 Mn |
| Jun 30, 2023 | -3.95 Mn |
| Mar 31, 2023 | -5.58 Mn |
| Mar 31, 2023 | -5.58 Mn |
| Dec 31, 2022 | -6.80 Mn |
| Dec 31, 2022 | -6.80 Mn |
| Sep 30, 2022 | -5.01 Mn |
| Sep 30, 2022 | -5.01 Mn |
| Jun 30, 2022 | -3.39 Mn |
| Jun 30, 2022 | -3.39 Mn |
| Mar 31, 2022 | -2.86 Mn |
| Mar 31, 2022 | -2.86 Mn |
| Dec 31, 2021 | -3.25 Mn |
| Dec 31, 2021 | -3.25 Mn |
| Sep 30, 2021 | -2.96 Mn |
| Sep 30, 2021 | -2.96 Mn |
| Jun 30, 2021 | -4.43 Mn |
| Jun 30, 2021 | -4.43 Mn |
| Mar 31, 2021 | -3.59 Mn |
| Mar 31, 2021 | -3.59 Mn |
| Dec 31, 2020 | -3.28 Mn |
| Dec 31, 2020 | -3.28 Mn |
| Sep 30, 2020 | -5.45 Mn |
| Sep 30, 2020 | -5.45 Mn |
| Jun 30, 2020 | -3.12 Mn |
| Jun 30, 2020 | -3.12 Mn |
| Mar 31, 2020 | -3.75 Mn |
| Mar 31, 2020 | -3.75 Mn |
| Dec 31, 2019 | -1.59 Mn |
| Dec 31, 2019 | -1.59 Mn |
| Sep 30, 2019 | -2.24 Mn |
| Sep 30, 2019 | -2.24 Mn |
| Jun 30, 2019 | -2.76 Mn |
| Jun 30, 2019 | -2.76 Mn |
| Mar 31, 2019 | -2.48 Mn |
| Mar 31, 2019 | -2.48 Mn |
| Dec 31, 2018 | -2.93 Mn |
| Dec 31, 2018 | -2.93 Mn |
| Sep 30, 2018 | -1.60 Mn |
| Sep 30, 2018 | -1.60 Mn |
| Jun 30, 2018 | -1.57 Mn |
| Jun 30, 2018 | -1.57 Mn |
| Mar 31, 2018 | -1.73 Mn |
| Mar 31, 2018 | -1.73 Mn |
| Dec 31, 2017 | -1.32 Mn |
| Dec 31, 2017 | -1.32 Mn |
| Sep 30, 2017 | -958,000.00 |
| Sep 30, 2017 | -958,000.00 |
| Jun 30, 2017 | -688,000.00 |
| Jun 30, 2017 | -688,000.00 |
| Mar 31, 2017 | -675,000.00 |
| Mar 31, 2017 | -675,000.00 |
| Dec 31, 2016 | -611,000.00 |
| Dec 31, 2016 | -611,000.00 |
| Sep 30, 2016 | -544,000.00 |
| Sep 30, 2016 | -544,000.00 |
| Jun 30, 2016 | -470,000.00 |
| Jun 30, 2016 | -470,000.00 |
| Mar 31, 2016 | -499,000.00 |
| Mar 31, 2016 | -499,000.00 |
| Dec 31, 2015 | -424,000.00 |
| Dec 31, 2015 | -424,000.00 |
| Sep 30, 2015 | -509,000.00 |
| Sep 30, 2015 | -509,000.00 |
| Jun 30, 2015 | -511,000.00 |
| Jun 30, 2015 | -511,000.00 |
| Mar 31, 2015 | -418,000.00 |
| Mar 31, 2015 | -418,000.00 |
| Dec 31, 2014 | -468,000.00 |
| Dec 31, 2014 | -468,000.00 |
| Sep 30, 2014 | -443,000.00 |
| Sep 30, 2014 | -443,000.00 |
| Jun 30, 2014 | -410,000.00 |
| Jun 30, 2014 | -410,000.00 |
| Mar 31, 2014 | -378,000.00 |
| Mar 31, 2014 | -378,000.00 |
| Dec 31, 2013 | -445,000.00 |
| Dec 31, 2013 | -445,000.00 |
| Sep 30, 2013 | -469,000.00 |
| Sep 30, 2013 | -469,000.00 |
| Jun 30, 2013 | -889,000.00 |
| Jun 30, 2013 | -889,000.00 |
| Mar 31, 2013 | -407,000.00 |
| Mar 31, 2013 | -407,000.00 |
| Dec 31, 2012 | -557,000.00 |
| Dec 31, 2012 | -557,000.00 |
| Sep 30, 2012 | -726,000.00 |
| Sep 30, 2012 | -726,000.00 |
| Jun 30, 2012 | -1.13 Mn |
| Jun 30, 2012 | -1.13 Mn |
| Mar 31, 2012 | -578,000.00 |
| Mar 31, 2012 | -578,000.00 |
| Dec 31, 2011 | -767,000.00 |
| Dec 31, 2011 | -767,000.00 |
| Sep 30, 2011 | -636,000.00 |
| Sep 30, 2011 | -636,000.00 |
| Jun 30, 2011 | 1.77 Mn |
| Jun 30, 2011 | 1.77 Mn |
| Mar 31, 2011 | -1.05 Mn |
| Mar 31, 2011 | -1.05 Mn |
| Dec 31, 2010 | -655,000.00 |
| Dec 31, 2010 | -655,000.00 |
| Sep 30, 2010 | -550,000.00 |
| Sep 30, 2010 | -550,000.00 |
| Jun 30, 2010 | -386,000.00 |
| Jun 30, 2010 | -386,000.00 |